Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson’s Disease

Recently, zonisamide (ZNS) has been approved as a new adjunctive therapy for motor complications of Parkinson’s disease (PD). More recently, ZNS was reported to be effective for the management of impulse control behavior in PD, suggesting potential effects on non-motor PD symptoms. Dream enactment associated with aggressive, violent behavior can carry a serious risk of injury to patients, as well as to spouses or caretakers. This report describes a patient with PD who had vivid nightmares and dream-enacting behavior that resolved after treatment with ZNS. The present case raises the question whether ZNS might potentially be effective for the management of vivid nightmares or dream-enacting behavior